References
- Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry 2004 Sep;75 Suppl 3:iii22-iii28.
- Musana AK, Yale SH. Central pontine myelinolysis: case series and review. Wis Med J 2005;104:56e60.
- Laubenberger J, Schneider B, Ansorge O, Götz F, Häussinger D, Volk B, Langer M. Central pontine myelinolysis: clinical presentation and radiologic findings. Eur Radiol. 1996;6(2):177–83.
- Finsterer J. Engelmayer E. Trinka E, et al. Immunoglobulins are effective in pontine myelinolysis. Clin Neuropharmacol. 2000 Mar- Apr;23(2):110–3.
- Deleu D, Salim K, Mesraoua B, El Siddig A, Al Hail H, Hanssens Y. “Man-in-the-barrel” syndrome as delayed manifestation of extrapontine and central pontine myelinolysis: beneficial effect of intravenous immunoglobulin. J Neurol Sci. 2005 Oct 15;237(1-2):103–6.
- Kallakatta RN, Radhakrishnan A, Fayaz RK, Unnikrishnan JP, Kesavadas C, Sarma SP. Clinical and functional outcome and factors predicting prognosis in osmotic demyelination syndrome (central pontine and/or extrapontine myelinolysis) in 25 patients. J Neurol Neurosurg Psychiatry. 2010 Sep 8.
- Shin HW, Song D, Sohn YH. Normal diffusion-weighted MR imaging predicts a good prognosis in extrapontine myelinolysis-induced parkinsonism. Mov Disord. 2009 Aug 15;24(11):1701–3.
- Kawahara I, Tokunaga Y, Ishizaka S, Yagi N. Reversible clinical and magnetic resonance imaging of central pontine myelinolysis following surgery for craniopharyngioma: serial magnetic resonance imaging studies. Neurol Med Chir (Tokyo). 2009 Mar;49(3):120–3.